Aquestive Therapeutics Inc (AQST)
3.10
-0.18
(-5.49%)
USD |
NASDAQ |
May 17, 16:00
3.10
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Accounts Payable (Quarterly): 10.52M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.52M |
| December 31, 2023 | 8.926M |
| September 30, 2023 | 9.994M |
| June 30, 2023 | 10.69M |
| March 31, 2023 | 12.44M |
| December 31, 2022 | 9.946M |
| September 30, 2022 | 11.07M |
| June 30, 2022 | 8.887M |
| March 31, 2022 | 8.496M |
| December 31, 2021 | 8.314M |
| September 30, 2021 | 6.215M |
| June 30, 2021 | 8.10M |
| March 31, 2021 | 6.687M |
| Date | Value |
|---|---|
| December 31, 2020 | 7.089M |
| September 30, 2020 | 9.169M |
| June 30, 2020 | 8.787M |
| March 31, 2020 | 10.28M |
| December 31, 2019 | 12.27M |
| September 30, 2019 | 14.20M |
| June 30, 2019 | 20.03M |
| March 31, 2019 | 19.14M |
| December 31, 2018 | 20.44M |
| September 30, 2018 | 12.34M |
| June 30, 2018 | 16.52M |
| March 31, 2018 | 10.99M |
| December 31, 2017 | 9.601M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
6.215M
Minimum
Sep 2021
20.03M
Maximum
Jun 2019
10.11M
Average
9.558M
Median
Accounts Payable (Quarterly) Benchmarks
| Lifecore Biomedical Inc | 22.14M |
| Harrow Inc | 12.57M |
| Akebia Therapeutics Inc | 11.88M |
| 89bio Inc | 15.35M |
| Humacyte Inc | 3.452M |